)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Vaxcyte
Vaxcyte (PCVX) investor relations material
Vaxcyte Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary23 Apr, 2026
Executive summary
Annual meeting scheduled for June 15, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials online or request copies by June 1, 2026.
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 annual meeting or until successors are qualified.
Ratification of Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026.
Advisory vote on the compensation of named executive officers (say-on-pay).
Proxies may vote on other business that may properly come before the meeting.
Board of directors and corporate governance
Nominees for Class III director positions: Olivier Brandicourt, M.D., Halley Gilbert, J.D., and Grant E. Pickering, M.B.A.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vaxcyte
- VAX-31 nears pivotal data and BLA filing as Group A Strep vaccine enters clinical trials.PCVX
Leerink Global Healthcare Conference 202629 Apr 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and strong governance practices.PCVXProxy filing23 Apr 2026
- Late-stage clinical progress, manufacturing scale-up, and strong cash position drive 2026 outlook.PCVXQ4 202517 Apr 2026
- Pivotal VAX-31 data and BLA filing expected within 15 months, backed by strong cash reserves.PCVX25th Annual Needham Virtual Healthcare Conference14 Apr 2026
- VAX-31 targets broad pneumococcal coverage, with phase 3 progress and 2028 launch planned.PCVXGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Apr 2026
- VAX-31 aims to set a new standard in pneumococcal disease prevention with unmatched coverage.PCVXCorporate presentation23 Mar 2026
- VAX-31's phase 3 progress and broad coverage position it for major impact in adult vaccination.PCVXTD Cowen 46th Annual Health Care Conference3 Mar 2026
- VAX-31 and VAX-24 advance as broadest-spectrum PCVs, supported by strong data and global strategy.PCVXCorporate presentation25 Feb 2026
- VAX-31 and VAX-24 aim to set new standards in pneumococcal disease coverage and market growth.PCVXCorporate presentation12 Feb 2026
Next Vaxcyte earnings date
Q1 20267 May, 2026
Vaxcyte
Next Vaxcyte earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage